Frontlight ResearchEarly access
Trial site
Nebraska Hematology - Oncology, P.C.
- 4running trials
- 2closed trials
The trials here
What the 6 trials at this site are about, from their registry records.
- Conditions
- Metastatic breast cancer3 trials
- Bladder cancer1 trial
- Chronic myeloid leukaemia1 trial
- Myeloproliferative neoplasms1 trial
- Phase
- Phase 33 trials
- Phase 22 trials
- Phase 1/21 trial
- Status
- Active, not recruiting3 trials
- Completed1 trial
- Recruiting1 trial
- Terminated1 trial
- Lead sponsor
- Novartis Pharmaceuticals2 trials
- Astellas Pharma Global Development, Inc.1 trial
- Celcuity Inc1 trial
- Eli Lilly and Company1 trial
- Kartos Therapeutics, Inc.1 trial
Running trials
Recruiting
Active, not recruiting
Active, not recruiting
Asciminib Monotherapy, With Dose Escalation, for 2nd and 1st Line Chronic Myelogenous Leukemia
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Myeloproliferative neoplasms1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 12 Nov 2026